title: A new window of opportunity to reject process-based biotechnology regulation.
abstract: The question of whether biotechnology regulation should be based on the process or the product has long been debated, with different jurisdictions adopting different approaches. The European Union has adopted a process-based approach, Canada has adopted a product-based approach, and the United States has implemented a hybrid system. With the recent proliferation of new methods of genetic modification, such as gene editing, process-based regulatory systems, which are premised on a binary system of transgenic and conventional approaches, will become increasingly obsolete and unsustainable. To avoid unreasonable, unfair and arbitrary results, nations that have adopted process-based approaches will need to migrate to a product-based approach that considers the novelty and risks of the individual trait, rather than the process by which that trait was produced. This commentary suggests some approaches for the design of such a product-based approach.
authors.affiliation: a Center for Law, Science & Innovation; Sandra Day O'Connor College of Law; Arizona State University ; Tempe , AZ USA.
authors.forename: Gary E
authors.initials: GE
authors.lastname: Marchant
authors.affiliation: a Center for Law, Science & Innovation; Sandra Day O'Connor College of Law; Arizona State University ; Tempe , AZ USA.
authors.forename: Yvonne A
authors.initials: YA
authors.lastname: Stevens
mesh_terms: D001709:Biotechnology / Q000331:legislation & jurisprudence* / Q000379:methods; D005060:Europe; D005818:Genetic Engineering / Q000331:legislation & jurisprudence* / Q000379:methods / Q000639:trends; D033161:Government Regulation; D030781:Organisms, Genetically Modified; D014481:United States
keywords: biotechnology, regulation, process-based, product-based, gene editing